KAPLAN M E, JANDL J H
J Exp Med. 1963 Jan 1;117(1):105-25. doi: 10.1084/jem.117.1.105.
Studies were undertaken in man and in the rat comparing the effects of rheumatoid factors and immune antiglobulins on red cells sensitized with incomplete antibodies. The interaction of immune antiglobulins with sensitized red cells produced (a) agglutination in vitro and (b) an accelerated sequestration of the sensitized cells in vivo. In contrast, rheumatoid macroglobulins, although capable of agglutinating Rh-sensitized red cells in vitro, did not modify their destruction in vivo. The failure of rheumatoid factors to function as antiglobulins in vivo appears to reflect their non-reactivity with sensitized cells in whole serum. It is suggested: (a) that the native (7S) gamma globulins of plasma competitively inhibit rheumatoid factors from reacting with fixed antibody in the blood stream; (b) that if these macroglobulins do indeed have pathogenetic activity, this may be limited to body fluids of low protein content.
在人体和大鼠中开展了研究,比较类风湿因子和免疫抗球蛋白对用不完全抗体致敏的红细胞的影响。免疫抗球蛋白与致敏红细胞的相互作用产生了:(a)体外凝集,以及(b)体内致敏细胞的加速潴留。相比之下,类风湿性巨球蛋白虽然能够在体外凝集Rh致敏的红细胞,但并未改变其在体内的破坏情况。类风湿因子在体内不能发挥抗球蛋白的作用,这似乎反映出它们在全血清中与致敏细胞无反应性。有人提出:(a)血浆中的天然(7S)γ球蛋白竞争性抑制类风湿因子与血流中的固定抗体发生反应;(b)如果这些巨球蛋白确实具有致病活性,那么这种活性可能仅限于蛋白质含量低的体液。